Sweden· SE-20080221000021
Granisetron Fresenius Kabi 1 mg/ml Injektionsvätska, lösning
A granisetron product containing granisetron hydrochloride, registered in Sweden by Fresenius Kabi AB. The same ATC class is registered in 18 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Granisetron is registered in 18 of 19 countries.
Countries holding a registration under ATC A04AA02 (granisetron), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 10 of them publish a price we can compare per daily dose
Granisetron · ATC A04AA02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of granisetron costs, country by country.
Normalised to the WHO defined daily dose (2 mg), the median price runs from $10.02 in Italy to $29.01 in Switzerland — a ×2.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Granisetron · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$29.01
- FR France$11.60
- IT Italy$10.02
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Granisetron Hydrochloride
- Manufacturer
- Fresenius Kabi AB
- Country
- Sweden (SE)
- ATC code
- A04AA02
- ATC class
- Granisetron
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20080221000021
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
564 interactions on record for granisetron.
Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Granisetron · interactions on record
564 records
- 139 severe
- 244 moderate
- 9 minor
- 172 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- FenfluramineA08AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Granisetron in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainGRANISETRON ACCORD 3MG/3ML SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- CzechiaGRANISETRON KABIFresenius Kabi s.r.o., Praha
- FinlandGranisetron OrionOrion Corporation
- BelgiumKytril 3 mg/3 mlAtnahs Pharma Netherlands
- United KingdomGranisetron 1mg tabletsCrescent Pharma Ltd
- United StatesGranisetronFresenius Kabi USA, LLC
- NetherlandsGranisetron Aurobindo 1 mg, filmomhulde tablettenAurobindo Pharma B.V.
- GermanyGraniDenk Pharma Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Granisetron Actavis, Kytril
- Belgium · Granisetron Fresenius Kabi, Kytril
- Bulgaria · Расетрон
- Czechia · Granegis, Granisetron Kabi
- Germany · Grani, Granisetron Baxter
- Denmark · Granisetron Hameln, Granisetron Stada
- Estonia · Kytril
- Spain · Granisetrón Altan, Granisetrón Aurovitas Spain
- Finland · Gazoron, Granisetron Baxter
- France · Kytril
- United Kingdom (Northern Ireland) · Granisetron, Granisetron Dawa
- Greece · Granitron, Viatrinil 1mg/Ml
- Croatia · Granizetron Kabi
- Hungary · Granegis, Granigen
- Ireland · Kytril
- Iceland · Grandise, Granem
- Italy · Grandise, Granem
- Liechtenstein · Sancuso
- Malta · Granisetron Sigillata
- Netherlands · Granisetron Baxter, Granisetron Fresenius Kabi
- Norway · Sancuso
- Portugal · Granisetron Orchid Europe, Granissetrom Aurovitas
- Romania · Granisetron Kabi, Granisetron Labormed
- Slovenia · Granisetron Lek, Kytril
- Slovakia · Emegar, Granegis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/72416d45-405e-45b3-b264-ac6612fe45c4 GET /v1/drugs/72416d45-405e-45b3-b264-ac6612fe45c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20080221000021",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20080221000021",
"product_doc_link": "https://docetp.mpa.se/LMF/Granisetron%20Fresenius%20Kabi%20solution%20for%20injection%20SmPC_09001bee807a403a.pdf"
}See everything about granisetron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.